SCHEMBL29627754

SCHEMBL29627754

Cc1ccc(OC(=O)c2ccccc2C(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2B Q14289 1/20 0.62
RXFP1 Q9HBX9 1/20 0.62
NPSR1 Q6W5P4 2/20 0.59
KMT2A Q03164 2/20 0.59
MEN1 O00255 1/20 0.59
AKR1C3 P42330 1/20 0.56
ALOX15 P16050 2/20 0.53
HPGD P15428 2/20 0.53
HSD17B10 Q99714 1/20 0.53
ALDH1A1 P00352 2/20 0.53
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
MAPT P10636 6/20 0.51
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
KDM4E B2RXH2 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10983921 0.93 PTK2B (0.66) PTK2BRXFP1NPSR1KMT2AMEN1
SCHEMBL208281 0.93 PTK2B (0.70) PTK2BRXFP1NPSR1KMT2AMEN1
SCHEMBL10783424 0.91 HSD17B10 (0.62) PTK2BRXFP1NPSR1KMT2AMEN1
SCHEMBL13985890 0.89 MAPT (0.55) PTK2BRXFP1NPSR1KMT2AMEN1
Phthalic Acid SCHEMBL9391164 0.87 HSD17B10 (0.68) NPSR1KMT2AAKR1C3ALOX15HPGD
SCHEMBL251479 0.87 HSD17B10 (0.68) NPSR1KMT2AAKR1C3ALOX15HPGD
SCHEMBL30778294 0.87 HSD17B10 (0.68) NPSR1KMT2AAKR1C3ALOX15HPGD
SCHEMBL30873163 0.86 TP53 (0.59) NPSR1KMT2AMEN1ALOX15HPGD
SCHEMBL4758943 0.86 TP53 (0.59) NPSR1KMT2AMEN1ALOX15HPGD
SCHEMBL27618569 0.85 HSD17B10 (0.66) NPSR1KMT2AAKR1C3ALOX15HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260121434-A1 APPARATUS HAVING ELECTRIC-FIELD ACTUATED GENERATOR FOR POWERING ELECTRICAL LOAD WITHIN VICINITY OF POWERLINES NXP AERONAUTICS RES LLC (US) 2026-04-30 US disclosed
US-11949267-B2 Apparatus having electric-field actuated generator for powering electrical load within vicinity of powerlines NXP AERONAUTICS RESEARCH, LLC (US) 2024-04-02 US disclosed
US-11865926-B2 Electric-field actuated generator for powering electrical load when within vicinity of powerlines including powering UAVs NXP AERONAUTICS RESEARCH, LLC (US) 2024-01-09 US disclosed
US-11731515-B2 Apparatus having electric-field actuated generator for powering electrical load within vicinity of powerlines NXP AERONAUTICS RESEARCH, LLC (US) 2023-08-22 US disclosed
US-11626729-B1 UAV airways systems and apparatus NXP AERONAUTICS RESEARCH, LLC (US) 2023-04-11 US disclosed
US-20230087075-A1 UAV AIRWAYS SYSTEMS AND APPARATUS NXP AERONAUTICS RES LLC (US) 2023-03-23 US disclosed
US-11476649-B1 Service entrance heads and methods WILSON SR LAURIN THOMAS (US) 2022-10-18 US disclosed
US-11431168-B2 UAV airways systems and apparatus NXP AERONAUTICS RESEARCH, LLC (US) 2022-08-30 US disclosed
EP-4018525-A1 UAV AIRWAYS SYSTEMS AND APPARATUS NXP Aeronautics Research, LLC (US) 2022-06-29 EP disclosed
US-11362501-B2 Insulator insert for weatherhead and methods of installing WILSON SR LAURIN T (US) 2022-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260121434-A1 APPARATUS HAVING ELECTRIC-FIELD ACTUATED GENERATOR FOR POWERING ELECTRICAL LOAD WITHIN VICINITY OF POWERLINES CACNA1C, CACNA1F, CACNA1S PTK2B 3443/4885RXFP1 3113/4885NPSR1 2892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.